Caribou Biosciences Inc Stock Ownership - Who owns Caribou Biosciences?

Insider buying vs selling

Have Caribou Biosciences Inc insiders been buying or selling?
Rachel E. HaurwitzPresident and CEO2023-06-0810,000$2.96
Rachel E. HaurwitzPresident and CEO2023-03-2010,000$2.96
Syed Aliaamir RizviChief Medical Officer2023-01-195,627$6.31
Steven KannerChief Scientific Officer2022-12-0221,401$2.69
Ryan FischesserVP of Finance and Controller2022-10-062,839$4.11
Ryan FischesserVP of Finance and Controller2022-10-0610,000$10.80
Ryan FischesserVP of Finance and Controller2022-10-062,839$2.69

1 of 1

CRBU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBU insiders and whales buy or sell their stock.

CRBU Shareholders

What type of owners hold Caribou Biosciences Inc stock?
Pfm Health Sciences LP6.31%5,570,869$28.36MInstitution
Blackrock Inc5.40%4,764,609$24.25MInstitution
Rachel E. Haurwitz3.84%3,389,395$17.25MInsider
Fmr LLC3.76%3,323,284$16.92MInsider
Avidity Partners Management LP3.12%2,758,600$14.04MInstitution
Bank Of America Corp3.12%2,751,490$14.01MInstitution
Rokos Capital Management LLP3.11%2,748,139$13.99MInstitution
Vanguard Group Inc2.90%2,560,231$13.03MInstitution
Elmwood Wealth Management Inc2.68%2,364,415$12.03MInstitution
Pictet Asset Management Sa2.05%1,809,261$9.21MInstitution

1 of 3

CRBU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBU49.51%8.62%Net Buying
AGEN55.36%35.09%Net BuyingNet Buying
ANAB41.71%58.29%Net SellingNet Selling
JANX56.17%43.83%Net BuyingNet Buying
MLYS56.19%43.81%Net BuyingNet Buying

Caribou Biosciences Stock Ownership FAQ

Who owns Caribou Biosciences?

Caribou Biosciences (NASDAQ: CRBU) is owned by 49.51% institutional shareholders, 8.62% Caribou Biosciences insiders, and 41.87% retail investors. Rachel E. Haurwitz is the largest individual Caribou Biosciences shareholder, owning 3.39M shares representing 3.84% of the company. Rachel E. Haurwitz's Caribou Biosciences shares are currently valued at $17.25M.

If you're new to stock investing, here's how to buy Caribou Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.